Literature DB >> 1104994

[Hypo and hypercalcemia as an emergency].

H G Haas, M A Dambacher, J Guncaga.   

Abstract

1. Hypo- and hypercalcemia can be explained as derangements of the calcium homeostasis. Hypocalcemic tetany usually alarming the patient tremendously is, at least in adults, rarely life-threatening. Hypercalcemia leads in 30% of the cases to clinical symptoms which may inadvertedly pass into a state of hypercalcemic crisis. This latter requires an often difficult emergency treatment. 2. Hypocalcemic tetany may be reversed by administering calcium i.v. or, in severe cases, by a calcium infusion. Only rarely are magnesium supplements necessary to let the tetany disappear. Vitamin D or dihydrotachysterol (DHT) do not correct hypocalcemia immediately, since their effects may be delayed up to 15-25 days. In order to normalize the serum calcium permanently, vitamin D or DHT treatment should be instituted as rarely as possible. 3. Initially, hypercalcemic crisis is best treated by forced intravenous fluid administration with normal saline (and furosemide) in combination with high doses of prednisone. Fluid-, sodium- and potassium balances ought to be checked during this type of treatment. A first evaluation of the effectiveness of these measures is recommended after 24 hours: treatment is continued in patients who respond favorably, while subjects who do not show a significant decrease of the serum calcium may either be given a phosphate infusion or mithramycine as a bolus. Calcitonin appears to be useful only to start treatment before institution of a phosphate infusion.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1104994     DOI: 10.1007/bf01468630

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  48 in total

Review 1.  [Problems in calcitonin research].

Authors:  H G Haas; M A Dambacher; J Guncaga; T Lauffenburger; C Lentner
Journal:  Klin Wochenschr       Date:  1972-01-01

2.  Chalk-eating as a cause of hypercalcaemia in a patient on haemodialysis.

Authors:  B Hulme; S L Cohen
Journal:  Lancet       Date:  1973-06-30       Impact factor: 79.321

Review 3.  Recent progress in calcium metabolism: clinical application.

Authors:  G S Gordan
Journal:  Calif Med       Date:  1971-05

4.  [Tetany-emergency in general practice].

Authors:  H G Haas
Journal:  Schweiz Med Wochenschr       Date:  1972-07-22

5.  Acute hypercalcemia due to Walker carcinosarcoma 256 in the rat.

Authors:  P Hilgard; W Schmitt; H Minne; R Ziegler
Journal:  Horm Metab Res       Date:  1970-07       Impact factor: 2.936

6.  Hypercalcemia as a complication of parenteral alimentation.

Authors:  R A Ulstrom; D M Brown
Journal:  J Pediatr       Date:  1972-08       Impact factor: 4.406

7.  Studies of the mechanism by which phosphate infusion lowers serum calcium concentration.

Authors:  L A Hebert; J Lemann; J R Petersen; E J Lennon
Journal:  J Clin Invest       Date:  1966-12       Impact factor: 14.808

8.  changes in serum and urinary calcium during treatment with hydrochlorothiazide: studies on mechanisms.

Authors:  A S Brickman; S G Massry; J W Coburn
Journal:  J Clin Invest       Date:  1972-04       Impact factor: 14.808

9.  Immunochemical localization of parathyroid hormone in cancer tissue from patients with ectopic hyperparathyroidism.

Authors:  G M Palmieri; R E Nordquist; G S Omenn
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

10.  Disorders of renal concentrating ability.

Authors:  F H Epstein
Journal:  Yale J Biol Med       Date:  1966-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.